GlassScriptPhysician profile
Harold Michael Mcswain
NPI 1033176458
$1,961.86
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $640 · 2021: $351 · 2022: $14.35 · 2024: $17.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $585.95 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $156.29 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $154.36 | 2019-2021 | |
| Blue Earth Diagnostics | $140.26 | 2019-2024 | |
| Allergan, INC. | $128.55 | 2019 | |
| Travere Therapeutics, INC. | $91.48 | 2019-2021 | |
| Amgen INC. | $90.77 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $90.13 | 2019 | |
| Pfizer INC. | $88.08 | 2019-2020 | |
| Rochester Medical Corporation | $74.34 | 2019-2020 | |
| Mission Pharmacal Company | $54.82 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $46.96 | 2020 | |
| Novartis Pharmaceuticals Corporation | $46.70 | 2020 | |
| Merck Sharp & Dohme LLC | $37.79 | 2020 | |
| Abbvie INC. | $29.87 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $26.49 | 2020-2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $26.04 | 2019 | |
| Janssen Biotech, INC. | $24.47 | 2019 | |
| Myovant Sciences INC. | $12.03 | 2021 | |
| Sun Pharmaceutical Industries INC. | $12.01 | 2019 | |
| Zyla Life Sciences, INC. | $11.55 | 2020 | |
| Clovis Oncology, INC. | $11.06 | 2020 | |
| Endo Pharmaceuticals INC. | $10.98 | 2020 | |
| Antares Pharma, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Mcswain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.